145 results on '"Rutten, Frans F."'
Search Results
2. Need For Differential Discounting Of Costs And Health Effects In Cost Effectiveness Analyses
3. The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk
4. Cost Utility Analysis of Sildenafil Compared with Papaverine-Phentolamine Injections
5. Burden of illness of Pompe disease in patients only receiving supportive care
6. I costi sanitari indiretti (non correlati) durante gli anni di vita guadagnati: Devono essere inclusi nelle valutazioni economiche degli interventi sanitari?
7. Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients
8. Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
9. Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted
10. Uitkomstenonderzoek: hoogste tijd voor een definitie!
11. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland
12. Unit Costs of Inpatient Hospital Days
13. The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands
14. Standardisation of Costs: The Dutch Manual for Costing in Economic Evaluations
15. Healthcare Resource Utilisation and Costs of Treating NSAID-Associated Gastrointestinal Toxicity: A Multinational Perspective
16. The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
17. The Cost of Treatment of Alzheimer’s Disease in The Netherlands: A Regression-Based Simulation Model
18. Cost Effectiveness of Continuous Terbinafine Compared with Intermittent Itraconazole in the Treatment of Dermatophyte Toenail Onychomycosis: An Analysis Based on Results from the L.I.ON. Study
19. Differences in Attitudes, Knowledge and Use of Economic Evaluations in Decision-Making in The Netherlands: The Dutch Results from the EUROMET Project
20. Cost of Illness in Adult Patients with Hypopituitarism
21. Incorporation of economic evidence in the Dutch guideline ‘cardiovascular risk management’
22. The Burden of Illness of Hypopituitary Adults with Growth Hormone Deficiency
23. Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective
24. Relationships among Self-Management, Patient Perceptions of Care, and Health Economic Outcomes for Decision-Making and Clinical Practice in Type 2 Diabetes
25. Treatment Costs and Quality of Life with Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Antineoplastic Therapy—Related Febrile Neutropenia: Results of a Randomised Placebo-Controlled Trial
26. Uncertainty in Decision-Making: Value of Additional Information in the Cost-Effectiveness of Lifestyle Intervention in Overweight and Obese People
27. A Practical Guide for Calculating Indirect Costs of Disease
28. The Cost Effectiveness of Diclofenac Plus Misoprostol Compared with Diclofenac Monotherapy in Patients with Rheumatoid Arthritis
29. Societal Perspective on the Burden of Migraine in The Netherlands
30. A Dollar Is a Dollar Is a Dollar—or Is It?
31. Indirect Costs in Economic Studies: Confronting the Confusion
32. Effects of ACE Inhibitors on Heart Failure in The Netherlands: A Pharmacoeconomic Model
33. Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs?
34. Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion
35. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis
36. Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial
37. Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial
38. Multidisciplinary Collaborative Care for Depressive Disorder in the Occupational Health Setting: design of a randomised controlled trial and cost-effectiveness study
39. Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial
40. Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial
41. Costs and Effects of Inhaled Corticosteroids and Bronchodilators in Asthma and Chronic Obstructive Pulmonary Disease
42. The Cost of Dental Implants as Compared to That of Conventional Strategies.
43. Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico.
44. VALUING QALY GAINS BY APPLYING A SOCIETAL PERSPECTIVE.
45. UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS.
46. Health Effects in Significant Others: Separating Family and Care-Giving Effects.
47. Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.
48. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics.
49. Multidisciplinary Collaborative Care for Depressive Disorder in the Occupational Health Setting: design of a randomised controlled trial and cost-effectiveness study.
50. Costs and prices of single dental fillings in Europe: a micro-costing study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.